Article
The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders
23 Aug 2024
Abstract excerpt
Safely and efficiently controlling gene expression is a long-standing goal of biomedical research, and CRISPR/Cas system can be harnessed to create powerful tools for epigenetic editing. Adeno-associated-viruses (AAVs) represent the delivery vehicle of choice for therapeutic platform. However, their small packaging capacity isn’t suitable for large constructs including most CRISPR/dCas9-effector vectors. Thus,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
